Sinai Health System
Toronto, Ontario, M5G1X2, Canada
NCT Number: NCT04055662
Cannabis is a drug that is widely used for recreational purpose. In most patients undergoing surgery, opioids are the most widely used mode of pain relief, during and following surgery. Anecdotally it has been observed that cannabis users required unexpectedly high doses of opioids. The purpose of this study is to compare opioid requirements between cannabis users and non- users after the surgery. Currently, post-operative opioid doses are determined based on various patient factors such as pre-operative opioid use, patient weight, age and sensitivity to opioids during surgery. Patients' requirements may be underestimated and opioid regimens need to be escalated in the first 24 hours in order to alleviate uncontrolled pain in cannabis users. Better understanding of the impacts of cannabis use on post-operative opioid requirements would help the Acute Pain Service optimize post-operative pain management for patients who use cannabis pre-operatively.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Toronto, Ontario, M5G1X2, Canada
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 2 years
Amount of morphine equivalents on PCA
Mount Sinai Hospital, Canada
Other
A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.